Contact this trialFirst, we need to learn more about you.
BTK Inhibitor
LOXO-305 for Mantle Cell Lymphoma
Recruiting2 awardsPhase 3
Tucson, Arizona
This trial is testing a new cancer drug against other approved drugs to see if it is more effective. It is for people with mantle cell lymphoma, a type of blood cancer, and could last up to two years.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.